“Patient Satisfaction With Tildrakizumab Treatment in a Phase 4 Real-World Study of Tildrakizumab in Patients With Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s134. Accessed July 22, 2025. https://skin.dermsquared.com/skin/article/view/2004.